Next Article in Journal
Young Nursing Student’s Knowledge and Attitudes about Contraceptive Methods
Next Article in Special Issue
Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040
Previous Article in Journal
FODMAP Intake in Spanish Population: Open Approach for Risk Assessment
Previous Article in Special Issue
Anti-Inflammatory and Antioxidative Potential of Aloe vera on the Cartap and Malathion Mediated Toxicity in Wistar Rats
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 17
Issue 16
10.3390/ijerph17165883
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Protective Effect of Xanthohumol on the Content of Selected Elements in the Bone Tissue for Exposed Japanese Quails to TCDD

by
Aleksandra Całkosińska
1,*,
Marzena Dominiak
1,
Sylwia Sobolewska
2,
Anna Leśków
3,
Małgorzata Tarnowska
3,
Aleksander Całkosiński
4 and
Maciej Dobrzyński
5
1
Department of Oral Surgery, Wroclaw Medical University, Krakowska 26 Street, 50-425 Wroclaw, Poland
2
Department of Animal Nutrition and Feed Management, Wroclaw University of Environmental and Life Sciences, Chelmonskiego 38c Street, 51-630 Wroclaw, Poland
3
Department of Nervous System Diseases, Faculty of Health Science, Wroclaw Medical University, Bartla Street 5, 51-618 Wroclaw, Poland
4
Students’ Scientific Association of Biomaterials and Experimental Dentistry, Wroclaw Medical University, Bujwida 44 Street, 50-368 Wroclaw, Poland
5
Department of Conservative Dentistry and Pedodontics, Wroclaw Medical University, Krakowska 26 Street, 50-425 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2020, 17(16), 5883; https://doi.org/10.3390/ijerph17165883
Submission received: 6 June 2020 / Revised: 4 August 2020 / Accepted: 5 August 2020 / Published: 13 August 2020
(This article belongs to the Special Issue Hazardous Compounds and Public Health: Programming the Future Based on Past Knowledge)
Browse Figures
Review Reports Versions Notes

Abstract

:
Dioxins (including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are highly toxic and persistent chemicals widely distributed in the environment in trace amounts, and are side products of industrial and chemical processes. Exposure to dioxins leads to multiorgan morphological and functional abnormalities, including within the bone tissue, disrupting its microarchitecture and mechanical properties. Xanthohumol (XN) is a chemical compound classified as a prenylated flavonoid, distinguished by multidirectional biological action. The aim of the study is to assess whether xanthohumol, as a substance with strong antioxidant and anti-inflammatory properties, has the ability to eliminate the negative effects of TCDD on bone tissue. The experiment was conducted on adult Japanese quails. Two different doses of TCDD and xanthohumol were administered to birds. After euthanasia of animals, the research material in the form of cranial vault and hind limb bone was collected, and their mineral compositions of calcium, phosphorus, magnesium, zinc, and iron concentrations were determined using atomic emission spectrometry in an acetylene-air flame method. Our results indicate that the administration of TCDD at a low dose causes more dynamic changes in the concentration of elements in bone, in comparison to a higher dose of dioxin. Results show also that higher doses of the XN cause the linear increase in the concentration of phosphorus and iron in the bone of the hind limb, and calcium in the bones of the cranial vault. In conclusion, our experiment shows that the use of TCDD and XN in Japanese quails together in various doses influences the content of phosphorus, magnesium, zinc, and iron in the research material.

1. Introduction

This research was undertaken to determine the effect of xanthohumol (XN) on biological effects caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in bone tissue. Dioxins are substances found in the environment in negligible amounts, formed as byproducts during industrial processes, such as production of herbicides, pesticides, and waste incineration [1,2,3]. Dioxins belong to the group of persistent organic compounds, and accumulate in the environment at every stage of the food chain. It leads to their accumulation in the adipose tissue of organisms, and permanent exposure to low doses of dioxins, which may result in the occurrence of various types of health disorders. In places where ecological disasters have occurred (e.g., Seveso (Italy)), the population is particularly exposed to the effects of dioxins. This justifies the search for pharmacological agents that have protective effects against dioxins. The best-known substance that represents this group is TCDD, which is classified as one of the most potent toxins. The molecular activity of dioxins is based on constant activation of the aryl hydrocarbon receptor (AhR), which, for example, induces the transcription of genes of different molecular forms of cytochrome P-450 (CYP), an enzyme responsible for metabolism of xenobiotics [4,5,6]. The exposure of organisms to dioxins causes numerous multi-organ disorders, for example, cancer progression, chloracne, liver enzymes overproduction, metabolism disruption, diabetes, reproductive disorders, thyroid function disorders, cardiovascular diseases, and also abnormalities of bone tissue, disrupting its microarchitecture and mechanical properties [7,8,9,10,11,12,13,14]. Based on the outcome of the experimental research, the TCDD has been shown to induce the oxidation stress, which causes the increase in the concentration of proinflammatory interleukins and activation of the osteoclastogenesis [15,16,17]. Moreover, the TCDD inhibits activity of alkaline phosphatase and the other initiators of mineralization. That can result in formation of hard tissues with low mineral levels [17,18]. The bones of the cranial vault and long bones differ in their histological structure, which is associated with their slightly various functions [4,19,20,21,22]. The intensity of bone metabolic processes is associated with the availability of transmission of signals—and therefore, with blood flow [23]. The bones are subjected to constant mechanical loads, and due to that, changes in the blood pressure and flow [24].
Bone remodeling is the key process for maintaining the required bone histophysiology, which depends on the activity of bone cells [25]. The disruption of this process may be associated with bone resorption abnormality associated with osteoblast activation, or may interfere with the activity of the osteoblasts responsible for the synthesis and mineralization of the bone and the osteoclast activation.
Xanthohumol (XN) is a bioactive substance obtained from female hop inflorescences (Humulus lupulus L.) with a range of biological properties [26]. The action of the XN on bone tissue is based mainly on the strong inhibition of bone resorption and the induction of osteogenesis. Depending on the dose, the XN stimulates the expression of osteogenic marker genes (Runx2, ALPL, and BGLAP), as well as alkaline phosphatase (ALP) activity in mesenchymal and preosteoblastic mouse cell lines [27]. The recent studies have shown that the XN significantly inhibits the bone resorption induced by NF-κB receptor activator ligand (RANKL) [28]. Xanthohumol can neutralize the effect of dioxins potentiating irregularities in the bone tissue related with osteoporosis. In the study of Gao et al. [29], the XN was shown to suppress the activity of T lymphocyte proliferation and cytokine production by Th1 lymphocytes (IL-2, IFN-γ and TNF-α). Activated T cells and the cytokines activated by them lead to RANKL expression on osteoblasts. In addition, stimulated T lymphocytes directly produce RANKL, which, by activating a specific RANK receptor, induces the formation and activation of osteoclasts [30]. In addition, it has been observed that xanthohumol can stimulate osteoblast differentiation, induce alkaline phosphatase (ALP) activity, and increase marker gene expression of RUNX2 osteoblasts in mouse MC3T3-E116 cells [31].
The XN as a phytoestrogen has the effect of inhibition of the differentiation and recruitment of osteoclasts; in this way it can inhibit the resorption process, causing the increase of the calcium content in bone [32]. On the other hand, it enhances the proliferation of various body cells, including osteoblasts [33].
Differently, in natural conditions, osteoblasts synthesize the bone matrix and then induce its mineralization. Presumably, a double dose of XN increased the proliferation of osteoblasts, which expanded the bone’s matrix volume without leading to its mineralization—this leads to decreased content of the calcium.
The described action of the XN was observed by Suh K.S. et al. in the paper about the impact of the XN on osteoblast differentiation [34]. This may mean that XN may have a multidirectional effect on the calcium content in the bone tissue by reducing its resorption or increasing osteoblast differentiation, depending on the adjustment. Available in vitro studies explain this mechanism only partially [33,34].
It was proven that administration of the substances, such as α-tocopherol, a powerful antioxidant antagonist of AhR, and acetylsalicylic acid, prevent the destructive influence of the TCDD on the bone tissue [35,36,37,38,39,40].
Based on evidence confirming the anti-inflammatory and antioxidant activity of xanthohumol, it can be assumed that this substance stimulates bone healing and has a protective effect against chemical damage associated with dioxin exposure [27,31,41].
The aim of this experiment was to determine the effect of xanthohumol on the bone tissue of organism exposed to dioxins.

2. Materials and Methods

2.1. Animals and Experimental Groups

The experimentation, transportation, and care of the animals were performed in compliance with the relevant laws and the institutional guidelines. The consent of the 1st Local Ethical Commission for Animal Experiments was obtained at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wroclaw, Weigla Street 12, 53-114 Wroclaw (consent number: 52/2015), before conduction of the experiment.
The experiment was performed on adult, female Japanese quails (Coturnix japonica) with a body weight of ca. 160 g. Birds were assigned to experimental groups by randomization. Japanese quails were chosen as an experimental model because of their significant sensitivity to dioxins [42].
Animals were kept in four-story metal cages, where the following conditions were provided: 15 air changes per hour, average temperature 25 °C, average humidity around 47%, light cycle 12/12 h. The temperature and humidity were measured each day of the experiment. Three or four birds were kept in each cage, due to the herd character of this species. Japanese quails were provided with constant access to water and fed ad libitum with complete mixtures. With constant access to feed, the herd hierarchy did not affect the animals’ ability to feed.
Birds were randomly assigned to nine groups, each with seven individuals (Table 1).
The experiment lasted 21 days. Feed intake was recorded daily. All quails were weighed on the first and the last day of the experiment. On the first day of the experiment, TCDD was administered to birds intramuscularly in two different doses (0.5 μg/kg body weight (b.w.) and 2 μg/kg b.w.) in groups IV, V, VI, VII, VIII, and IX. Xanthohumol was administered to animals by intramuscular injection the first, seventh, and fourteenth days of experiment at a dose of 10 mg/kg b.w. and 20 mg/kg b.w. in groups II, III, V, VI, VIII, and IX.
Quails were euthanized after 21 days from the beginning of experiment. Tested tissue in the form of bone of cranial calvaria and hind limb was collected from animals. Obtained samples were placed in sterile containers and frozen at the temperature of −73 °C.

2.2. Chemical Substances Used in the Experiment

The following substances were used in the study: xanthohumol (Department of Chemistry, Faculty of Biotechnology and Food Sciences, Wroclaw University of Environmental and Life Sciences); 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) standard solution (Greyhound Chromatography and Allied Chemicals, No. DD-2378-S) dissolved in dimethyl sulfoxide (DMSO) at a concentration of 5 μg/mL was prepared in Department of Chemistry, Faculty of Biotechnology and Food Sciences, Wroclaw University of Environmental and Life Sciences; and thiopental (Biochemie GmbH, Vienna, Austria.

2.3. Determination of the Mineral Composition of the Cranial Vault and Hind Limb Bone of Examined Animals

The mineral composition of the cranial vault and hind limb bone was determined by assessing the concentration of calcium (Ca), phosphorus (P), magnesium (Mg), zinc (Zn), and iron (Fe).

2.3.1. Mineralization of Bone Tissue Samples

The mineralization of samples was carried out in a closed, wet digestion microwave system. To the homogeneous sample of bone (from 0.1 g to 0.5 g), 5 cm3 of concentrated nitric acid (V) and 1 cm3 concentrated hydrogen peroxide were added. Then, the samples were mineralized in a MARS 5 microwave sample preparation system. Mineralizates were transferred to measuring vessels with the capacity 10 cm3, using redistilled water.

2.3.2. Determination of the Concentration of Calcium, Phosphorus, Magnesium, Zinc, and Iron in the Skull Bone and Hind Limb of the Tested Birds

The calcium content was determined by the method of atomic emission spectrometry in an acetylene-air flame, using the SpectrAA atomic absorption spectrometer with a Varian AA240FS flame adapter. The phosphorus content was determined by spectrophotometry, using a Unicam UV300 spectrophotometer from ThermoSpectronic. The determination of zinc, iron, and magnesium content was carried out by the absorption spectrometry method in an acetylene-air flame, using the SpectrAA atomic absorption spectrometer with a Varian AA240FS flame adapter.
The concentrations of chemical elements in tested material were determined in accordance with the following standards: European Standard PN-EN 13805: 2014-11; calcium determination according to the Research Procedure PB-06/AAS; determination of phosphorus according to the Polish Standard PN-EN ISO 3946: 2000; magnesium determination according to the Polish Standard PN-EN 15505: 2009; determination of zinc and iron according to the Polish Standard PN-EN 14082: 2004.

2.3.3. Statistical Analysis

The development of research results consisted of the calculation of basic descriptive statistics of elemental values (mean, standard deviation, median, quartiles, and extreme values). The Bartlett’s test was used to check the homogeneity of the variance of results. The significance of the effect of two controlled factors, TCDD and xanthohumol, on the content of the analyzed elements in the bone of cranial vault and hindlimb was verified on the basis of two-factor analysis of variance. Because the empirical distributions were significantly different from the normal distribution, the raw results were subjected to Box–Cox transformation. All hypotheses were verified at the significance level p ≤ 0.05. Statistical analysis was performed using the STATISTICS 13 PL.

3. Results

3.1. Calcium

The only factor that significantly affected the content of calcium in cranial vault bone was the dose of xanthohumol (p < 0.001). The dose of 10 mg/kg b.w. caused a significant increase in concentration of calcium. The increase of dose to 20 mg/kg b.w. reduced calcium levels (Figure 1a).
The only factor that significantly affected calcium content in the hind limb bone was the dose of TCDD (p < 0.05). The doses of 0.5 μg/kg b.w. and 2 μg/kg b.w. caused a significant increase in Ca concentration (Figure 1b).

3.2. Phosphorus

Both dioxin TCDD (p < 0.001) and xanthohumol (p < 0.001) proved to be factors that significantly reduced the phosphorus content in the bone of the cranial vault of the birds. No statistically significant correlation of these factors was observed (p > 0.05). Increasing the dose of xanthohumol caused a linear decrease in phosphorus content, while in the case of TCDD, even a dose of 0.5 μg per kilogram of body weight caused a sharp decrease in phosphorus concentration in the cranial vault bone (Figure 2a).
The change in phosphorus content in the bones of the hind limb was significantly influenced by the dose of xanthohumol (p < 0.01). A dose of xanthohumol 10 mg per kilogram of body weight caused a sharp increase in phosphorus content (p < 0.01), and its further increase had no significant effect. The effect of TCDD on the phosphorus content was small. Only a dose of 2 μg per kilogram of body weight caused a slight decrease in phosphorus concentration. A statistically significant correlation between the dose of xanthohumol and TCDD was also observed (p < 0.05) (Figure 2b).

3.3. Magnesium

The magnesium concentration in the bone of cranial vault depended significantly on both factors. There was also a statistically significant correlation between TCDD and xanthohumol. No statistically significant results were obtained for the magnesium content in the hind limb of the tested animals (Figure 3).

3.4. Zinc

The concentration of zinc in the bones of cranial vault depended significantly on both factors. There was also a statistically significant correlation between TCDD and xanthohumol. The content of this element in the bone of the hind limb significantly depended on the dose of dioxin. There was also a statistically significant correlation between TCDD and xanthohumol (Figure 4a,b).

3.5. Iron

The concentration of iron in the bones of cranial vault depended significantly on both factors. However, no statistically significant correlation was observed between the levels of TCDD and xanthohumol. The concentration of iron in the bones of the hind limb depended significantly on both factors. There was also a statistically significant correlation between TCDD and xanthohumol (Figure 5a,b).

4. Discussion

In previous studies, a negative effect of dioxins on the bone tissue, associated with their pro-inflammatory properties and ability to induce oxidative stress, has been demonstrated [9,15,43]. The purpose of the carried-out experiment was to determine the effect of XN on the bone tissue after administration of TCDD in tested animals. The indicator of this dependency is the mineral composition of cranial vault bone and hind limb of Japanese quail treated with TCDD and xanthohumol. The assessment of phosphorus, calcium, magnesium, zinc, and iron content makes it possible to determine the effectiveness of bone tissue mineralization processes in tested animals [44,45,46]. Calcium and phosphorus are the building materials of the calcium dihydroxyapatite crystal, which is the basic structural unit of bone tissue, forming an ordered crystal network undergoing constant physiological reconstruction. Magnesium, zinc, and iron are elements that play an important role in regulation of bone metabolism. Previous experimental studies have proven the adverse effects of dioxins as environmental factors on bone remodeling in the experimental animals, both in developmental and adult age [43]. It was found that exposure to TCDD led to decrease of bone mechanical strength and caused an increase in density of cortical bone in studied adult rats [4,19,47,48,49].
In the experiment conducted on animals during prenatal and lactation period, an adverse effect of dioxins on the size, strength, and mineralization of bones was observed [50]. Similar results were obtained, in their studies, by Miettinen et al. [11], exposing dioxin to female rats at various periods of pregnancy and lactation. In the offspring of groups exposed to TCDD, bone length, cortical cross-sectional area, and mineral density decreased. Mechanical tests showed significantly reduced tibial and femoral fracture strength, as well as their increased stiffness.
In Dobrzyński’s experiment [50], the reduction of calcium content in bone material, in the form of cranial vault and knee joint, was demonstrated in rat newborns whose mothers were given TCDD at a dose of 5 μg/kg b.w. Moreover, other studies found that the offspring of TCDD-treated mice have abnormalities in the size and shape of the jaw and cleft palate [51,52].
Our research carried out as part of this study confirms the effect of dioxins on the bone, resulting in disorders in its mineral composition. It was observed that the use of TCDD only at a dose of 0.5 μg/kg b.w. led to a sharp decrease in the concentrations of phosphorus, magnesium, zinc, and iron, while the dose of 2 μg/kg b.w. caused a significant reduction in the calcium content in the bone of the cranial vault of the tested Japanese quail. In the hind limb of animals exposed to a lower dose of dioxin, there was a decrease in zinc and iron, and—interestingly—a significant increase in calcium. According to Lind et al. [53], increased calcium content in the bone of rats exposed to TCDD can be associated with the disturbed mineralization of this tissue, and inhibition of osteocytic osteolysis, which is a characteristic feature for older animals and may negatively affect the bone’s mechanical properties.
Our research conducted as part of this experiment also shows that a higher dose of dioxin led to a significant decrease in the concentrations of phosphorus, calcium, and zinc. The bone’s mineral disorders may be associated with the induction of inflammation and oxidative stress by increasing the expression of proinflammatory cytokines and COX-2 [43,50], which may result in imbalance between bone mineralization and resorption in favor of catabolic processes.
The previous reports confirm the need to search for substances that eliminate or reduce the effects of dioxins on the bone tissue [4,19,48,50].
Dobrzyński et al. showed a beneficial effect of tocopherol and acetylsalicylic acid on the concentrations of calcium and magnesium in the bones of the cranial vault and knee joint, which was observed in the offspring of rats exposed to TCDD [54]. This confirms the important role of substances with anti-inflammatory and antioxidant properties in reducing the biological effects of dioxins.
The XN characterized by the above-described properties can neutralize the effects of dioxins potentiating irregularities in bone tissue. In studies performed on mice with ovariectomy-induced osteoporosis, the severity of bone resorption decreased. The XN administration to the animals was started four weeks after ovarian resection, and was treated for five weeks. The histomorphometric analysis of the lumbar vertebrae showed that trabecular bone volume was significantly higher in XN-treated mice. The results confirming the beneficial effects of prenylated flavonoids on bone resorption associated with osteoporosis were also obtained by Ban et al. [55]. The use of Lifenol®, which contains hops extracts, in ovariectomized rats significantly reduced the decrease in bone mineral density and mineral content. It has been observed that XN stimulates osteoblast differentiation by activating the RUNX2 transcription factor [56]. However, in the experiment performed on osteoblasts of the MC3T3-E1 line treated with TCDD, the level of protein kinase C and NF-κB increased. Nevertheless, the presence of XN alleviated the pathological effects of TCDD and led to an increase in gene expression associated with osteoblast differentiation, such as alkaline phosphatase, osteocalcin, and osteoprotegerin [34].
The eliminating effects of XN on the biological effects induced by TCDD administration may be related to the ability of prenylated flavonoids to block the activation reaction mediated by cytochrome P450, which was observed in studies carried out in various in vitro systems. In a study by Henderson et al. [57], the XN caused complete inhibition of resorufin O-deetylase (EROD) CYP1A1 and CYP1B1 at an appropriate concentration, while showing less effect on CYP2E1 and CYP3A4.
Our own research showed that the use of only XN at a dose of 10 mg/kg b.w. led to an increase in calcium content in the cranial vault bone.
The use of xanthohumol at a dose of 10 mg/kg b.w. and 20 mg/kg b.w. in animals subjected to dioxin exposure (0.5 μg/kg b.w.) led to a marked reduction in the dynamics of the decrease in magnesium and zinc content in the bone of the cranial vault, and an increase in phosphorus and zinc in the hind limb of tested animals.
When using dioxin at a dose of 2 μg/kg b.w. in combination with xanthohumol at a dose of 10 mg/kg or 20 mg/kg b.w., there was always substantial decrease in the content of individual mineral substances. This result may indicate that the used dose of xanthohumol was insufficient to eliminate the effect of dioxin on bone tissue at a dose of 2 μg/kg b.w. of TCDD in Japanese quails tested.
Nevertheless, it can be stated that xanthohumol limits the intensity of demineralization processes in the bone tissue induced by dioxin, and has osteoprotective effects.

5. Conclusions

  • The administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Japanese quails at a low dose causes more dynamic changes in the concentration of elements in bone in comparison to a higher dose of dioxin. For most bioelements (P, Mg, Zn, Fe), there is a sharp decrease in their content noticed, except for calcium, whose concentration increased significantly.
  • Higher doses of the XN cause the linear increase in the concentrations of phosphorus and iron in the bone of the hind limb, and calcium in the bones of cranial vault. Most often, increasing the dose of xanthohumol led to a linear decrease in the content of bioelements.
  • The use of dioxin and xanthohumol in Japanese quails together in various doses influenced the content of phosphorus, magnesium, zinc, and iron in the research material.

Author Contributions

Conceptualization: A.C. (Aleksandra Całkosińska); methodology: S.S.; formal analysis: A.L.; investigation: A.C. (Aleksander Całkosiński); resources: S.S.; data curation: M.T.; writing—original draft preparation: A.C. (Aleksandra Całkosińska); writing—review and editing: M.D. (Maciej Dobrzyński); supervision: M.D. (Marzena Dominiak); project administration: M.D. (Maciej Dobrzyński); funding acquisition: A.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Wroclaw Medical University-statutory activity ST.E020.17.051.

Acknowledgments

The authors would like to thank Ireneusz Całkosiński (1951–2017) for inspiration, valuable advice, and support in the organization and welfare of the animals.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Marinković, N.; Pašalić, D.; Ferenčak, G.; Gršković, B.; Rukavina, A. Dioxins and Human Toxicity. Arch. Ind. Hyg. Toxicol. 2010, 61, 445–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Shibamoto, T.; Yasuhara, A.; Katami, T. Dioxin formation from waste incineration. Rev. Environ. Contam. Toxicol. 2007, 190, 1–41. [Google Scholar] [PubMed]
  3. Zhu, J.; Hirai, Y.; Sakai, S.; Zheng, M. Potential source and emission analysis of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans in China. Chemosphere 2008, 73, 72–77. [Google Scholar] [CrossRef] [PubMed]
  4. Dobrzyński, M.; Pezowicz, C.; Tomanik, M.; Kuropka, P.; Dudek, K.; Fita, K.; Styczynska, M.; Wiglusz, R.J. Modulating effect of selected pharmaceuticals on bone in female rats exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD). RSC Adv. 2018, 8, 27537. [Google Scholar] [CrossRef] [Green Version]
  5. Gostomska-Pampuch, K.; Ostrowska, A.; Kuropka, P.; Dobrzyński, M.; Ziółkowski, P.; Kowalczyk, A.; Łukaszewicz, E.; Gamian, A.; Całkosiński, I. Protective effects of levamisole, acetylsalicylic acid, and alpha-tocopherol against dioxin toxicity measured as the expression of AhR and COX-2 in a chicken embryo model. Histochem. Cell Biol. 2017, 147, 523–536. [Google Scholar] [CrossRef] [Green Version]
  6. Calkosinski, I.; Rosinczuk-Tonderys, J.; Dobrzynski, M.; Pałka, Ł.; Bazan, J. Occurrence of disseminated intravascular coagulation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced pneumonia in the rat neurobiology of respiration. Adv. Exp. Med. Biol. 2013, 788, 283–292. [Google Scholar]
  7. Boffetta, P.; Mundt, K.; Adami, H.; Cole, P.; Mandel, J. TCDD and cancer: A critical review of epidemiologic studies. Crit. Rev. Toxicol. 2011, 41, 622–636. [Google Scholar] [CrossRef]
  8. Brouwer, A.; Ahlborg, U.G.; Rolaf ven Leeuwen, F.X.; Feeley, M.M. Report of the WHO working group on the assessment of health risks for human infants from exposure to PCDDS, PCDFS and PCBS. Chemosphere 1998, 37, 1627–1643. [Google Scholar] [CrossRef]
  9. Guo, Y.L.; Lambert, G.H.; Hsu, C.C.; Hsu, M.M.L. Yucheng: Health effects of prenatal exposure to polychlorinated biphenyls and dibenzofurans. Int. Arch. Occup. Environ. Health 2004, 77, 153–158. [Google Scholar] [CrossRef]
  10. Herlin, M.; Kalantari, F.; Stern, N.; Sand, S.; Larsson, S.; Viluksela, M.; Tuomisto, J.T.; Tuomisto, J.; Tuukkanen, J.; Jämsä, T.; et al. Quantitative characterization of changes in bone geometry, mineral density and biomechanical properties in two rat strains with different ah-receptor structures after long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 2010, 273, 1–11. [Google Scholar] [CrossRef] [Green Version]
  11. Miettinen, H.; Pulkkinen, P.; Jämsä, T.; Koistinen, J.; Simanainen, U.; Tuomisto, J.; Tuukkanen, J.; Viluksela, M. Effects of in utero and lactational TCDD exposure on bone development in differentially sensitive rat lines. Toxicol. Sci. 2005, 85, 1003–1012. [Google Scholar] [CrossRef] [PubMed]
  12. Yoshida, R.; Ogawa, Y. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: An application of oxidative stress markers to cancer risk assessment of dioxins. Ind. Health 2000, 38, 5–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Całkosiński, I.; Rosińczuk-Tonderys, J.; Bazan, J.; Dobrzyński, M.; Bronowicka-Szydełko, A.; Dzierzba, K. Influence of dioxin intoxication on the human system and possibilities of limiting its negative effects on the environment and living organisms. Ann. Agric. Environ. Med. 2014, 21, 518–524. [Google Scholar] [CrossRef] [PubMed]
  14. Dobrzyński, M.; Całkosiński, I.; Przywitowska, I.; Kobierska-Brzoza, J.; Czajczyńska-Waszkiewicz, A.; Sołtan, E.; Parulska, O. Effects of dioxins in environmental pollution on development of tooth disorders. Pol. J. Environ. Stud. 2009, 18, 319–323. [Google Scholar]
  15. Całkosiński, I.; Rosińczuk-Tonderys, J.; Szopa, M.; Dobrzyński, M.; Gamian, A. Zastosowanie wysokich dawek tokoferolu w prewencji i potencjalizacji działania dioksyn w doświadczalnym zapaleniu. Postep. Hig. Med. Dosw. 2011, 65, 143–157. [Google Scholar] [CrossRef]
  16. Andreasen, E.A.; Mathew, L.K.; Lohr, C.V.; Hasson, R.; Tanguay, R.L. Aryl hydrocarbon receptor activation impairs extracellular matrix remodeling during zebra fish fin regeneration. Toxicol. Sci. 2007, 95, 215–226. [Google Scholar] [CrossRef]
  17. Singh, S.U.; Casper, R.F.; Fritz, P.C.; Sukhu, B.; Ganss, B.; Girard, B.; Savouret, J.F.; Tenenbaum, H.C. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. Endocrinology 2000, 167, 183–195. [Google Scholar] [CrossRef] [Green Version]
  18. Kiukkonen, A.; Viluksela, M.; Sahlberg, C.; Alaluusua, S.; Tuomisto, J.T.; Tuomisto, J.; Lukinmaa, P.L. Response of the incisor tooth to 2,3,7,8- tetrachlorodibenzo-p-dioxin in a dioxin-resistant and a dioxin-sensitive rat strain. Toxicol. Sci. 2002, 69, 482–489. [Google Scholar] [CrossRef] [Green Version]
  19. Dobrzynski, M.; Kuropka, P.; Tarnowska, M.; Styczynska, M.; Dudek, K.; Leskow, A.; Targonska, S.; Wiglusz, R.J. The protective effect of α-tocopherol on the content of selected elements in the calvaria for exposed hens to TCDD in the early embryonic period. Biol. Trace Elem. Res. 2018, 190, 517–525. [Google Scholar] [CrossRef]
  20. Florencio-Silva, R.; Rodrigues da Silva Sasso, G.; Sasso-Cerri, E.; Simões, M.J.; Cerri, P.S. Biology of bone tissue: Structure, function, and factors that influence bone cells. Biomed. Res. Int. 2015, 2015, 421746. [Google Scholar] [CrossRef] [Green Version]
  21. Langdahl, B.; Ferrari, S.; Dempster, D.W. Bone modeling and remodeling: Potential as therapeutic targets for the treatment of osteoporosis. Ther. Adv. Musculoskelet. Dis. 2016, 8, 225–235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Eriksen, E.F. Cellular mechanisms of bone remodeling. Rev. Endocr. Metab. Disord. 2010, 11, 219–227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Ramasamy, S.K.; Kusumbe, A.P.; Schiller, M.; Zeuschner, D.; Bixel, M.G.; Milia, C.; Gamrekelashvili, J.; Limbourg, A.; Medvinsky, A.; Santoro, M.M.; et al. Blood flow controls bone vascular function and osteogenesis. Nat. Commun. 2016, 7, 13601. [Google Scholar] [CrossRef]
  24. Prisby, R.D. Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone. J. Endocrinol. 2017, 235, R77–R100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Raggatt, L.J.; Partridge, N.C. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 2010, 285, 25103–25108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Kłósek, M.; Mertas, A.; Król, W.; Jaworska, D.; Szymszal, J.; Szliszka, E. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells after treatment with xanthohumol—A natural compound present in humulus lupulus L. Int. J. Mol. Sci. 2016, 17, 837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Hyung, J.; Eun Hee, H.; Yun, J.; You Ch Kwang, L.; Hye, J. Xanthohumol from the hop plant stimulates osteoblast differentiation by RUNX2 activation. Biochem. Biophys. Res. Commun. 2011, 409, 82–89. [Google Scholar]
  28. Suh, K.S.; Rhee, S.Y.; Kim, Y.S.; Lee, Y.S.; Choi, E.M. Xanthohumol modulates the expression of osteoclast-specific genes during osteoclastogenesis in RAW264.7 cells. Food Chem. Toxicol. 2013, 62, 99–106. [Google Scholar] [CrossRef]
  29. Gao, X.; Deeb, D.; Liu, Y.; Gautam, S.; Dulchavsky, S.A.; Gautam, S.C. Immunomodulatory activity of xanthohumol: Inhibition of T cell proliferation, cell-mediated cytotoxicity and th1 cytokine production through suppression of NF-κB. Immunopharmacol. Immunotoxicol. 2009, 31, 477–484. [Google Scholar] [CrossRef] [Green Version]
  30. Cho, Y.; Kim, H.; Kim YLee, K.Y.; Choi, H.J.; Lee, I.S.; Kang, B.Y. Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages. Int. Immunopharmacol. 2008, 8, 567–573. [Google Scholar] [CrossRef]
  31. Liu, M.; Hansen, P.; Wang, G.; Qiu, L.; Dong, J.; Yin, H.; Qian, Z.; Yang, M.; Miao, J. Pharmacological profile of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus). Molecules 2015, 20, 754–779. [Google Scholar] [CrossRef] [PubMed]
  32. Li, J.; Zeng, L.; Xie, J.; Yue, Z.; Deng, H.; Ma, X.; Zheng, C.; Wu, X.; Luo, J.; Liu, M. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a Prenylflavonoid Xanthohumol from Hops. Sci. Rep. 2015, 5, 17605. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Suh, K.S.; Chon, S.; Choi, E.M. Cytoprotective effects of xanthohumol against methylglyoxal-induced cytotoxicity in MC3T3-E1 osteoblastic cells. J. Appl. Toxicol. 2017, 38, 180–192. [Google Scholar] [CrossRef] [PubMed]
  34. Suh, K.S.; Choi, E.M.; Kim, H.S.; Park, S.Y.; Chin, S.O.; Rhee, S.Y.; Pak, Y.K.; Choe, W.; Ha, J.; Chon, S. Xanthohumol ameliorates 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cellular toxicity in cultured MC3T3-E1 osteoblastic cells. J. Appl. Toxicol. 2018, 38, 1036–1046. [Google Scholar] [CrossRef] [PubMed]
  35. Hirai, K.I.; Pan, J.H.; Shui, Y.B.; Simamura, E.; Shimada, H.; Kanamaru, T.; Koyama, J. Alpha-tocopherol protects cultured human cells from the acute lethal cytotoxicity of dioxin. Int. J. Vitam. Nutr. Res. 2002, 72, 147–153. [Google Scholar] [CrossRef] [PubMed]
  36. Alaluusua, S.; Lukinmaa, P.-L.; Pohjanvirta, R.; Unkila, M.; Tuomisto, J. Exposure to 2,3,7,8-tetrachlorodibenzo-para-dioxin leads to defective dentin formation and pulpal perforation in rat incisor tooth. Toxicology 1993, 81, 1–13. [Google Scholar] [CrossRef]
  37. Catley, M.C.; Birrell, M.A.; Hardaker, E.L.; de Alba, J.; Farrow, S.; Haj-Yahia, S.; Belvisi, M.G. Estrogen receptor: Expression profile and possible anti-inflammatory role in disease. J. Pharmacol. Exp. Ther. 2008, 326, 83–88. [Google Scholar] [CrossRef] [Green Version]
  38. Alsharif, N.Z.; Hassoun, E.A. Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)- induced body wasting, hepatomegaly, thymic atrophy, productionof reactive oxygen species and DNA damage in C57BL/6J mice. Basic Clin. Pharmacol. Toxicol. 2004, 95, 131–138. [Google Scholar] [CrossRef]
  39. Fernandez-Salguero, P.; Hilbert, D.; Rudikoff, S.; Ward, J.; Gonzalez, F. Arylhydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin- induced toxicity. Toxicol. Appl. Pharmacol. 1996, 140, 173–179. [Google Scholar] [CrossRef]
  40. MacDonald, C.J.; Ciolino, H.P.; Yeh, G.C. The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 2004, 64, 429–434. [Google Scholar] [CrossRef] [Green Version]
  41. Takayanagi, H.; Ogasawara, K.; Hida, S.; Chiba, T.; Murata, S.; Sato, K.; Takaoka, A.; Yokochi, T.; Oda, H.; Tanaka, K.; et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000, 408, 600–605. [Google Scholar] [CrossRef] [PubMed]
  42. U.S. Environmental Protection Agency. Framework for Application of the Toxicity Equivalence Methodology for Polychlorinated Dioxins, Furans, and Biphenyls in Ecological Risk Assessment; U.S. Environmental Protection Agency: Washington, DC, USA, 2008.
  43. Całkosiński, I. The Influence of Tocopherol on Diagnostic Indexes of Inflammatory Reaction in Rats Undergoing Dioxin Exposition. Habilitation Thesis, Wroclaw Medical University, Wroclaw, Poland, 2008. [Google Scholar]
  44. Łabądź, D.; Skolarczyk, J.; Pekar, J.; Nieradko-Iwanicka, B. Analysis of the influence of selected elements on the functioning of the bone tissue. J. Educ. Health Sport 2017, 7, 202–209. [Google Scholar]
  45. Darrah, T. Inorganic Trace Element Composition of Modern Human Bones: Relation to Bone Pathology and Geographical Provenance. Ph.D. Thesis, University of Rochester, Rochester, NY, USA, 2009. [Google Scholar]
  46. Castiglioni, S.; Cazzaniga, A.; Albisetti, W.; Maier, J. Magnesium and osteoporosis: Current state of knowledge and future research directions. Nutrients 2013, 5, 3022–3033. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Jämsä, T.; Viluksela, M.; Tuomisto, J.T.; Tuomisto, J.; Tuukkanen, J. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on bone in two rat strains with different aryl hydrocarbon receptor structures. J. Bone Miner. Res. 2001, 16, 1812–1820. [Google Scholar] [CrossRef]
  48. Dobrzyński, M.; Kuropka, P.; Tarnowska, M.; Dudek, K.; Styczyńska, M.; Lesków, A.; Targońska, S.; Wiglusz, R.J. Indirect study of the effect of α-tocopherol and acetylsalicylic acid on the mineral composition of bone tissue in the offspring of female rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: Longterm observations. RSC Adv. 2019, 9, 8016. [Google Scholar] [CrossRef] [Green Version]
  49. Carpi, D.; Korkalainen, M.; Airoldi, L.; Fanelli, R.; Hakansson, H.; Muhonen, V.; Tuukkanen, J.; Viluksela, M.; Pastorelli, R. Dioxin-sensitive proteins in differentiating osteoblasts: Effects on bone formation in vitro. Toxicol. Sci. 2009, 108, 330–343. [Google Scholar] [CrossRef] [Green Version]
  50. Dobrzyński, M. The Influence of Tocopherol and Acetylsalicylic Acid on Tooth Organ Structure in Offspring of Rat Dams Undergoing 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD); Wroclaw Medical University: Wroclaw, Poland, 2012. [Google Scholar]
  51. Allen, D.E.; Leamy, L.J. 2,3,7,8-tetrachlorodibenzo-p-dioxin affects size and shape, but not asymmetry, of mandibles in mice. Ecotoxicology 2001, 10, 167–176. [Google Scholar] [CrossRef]
  52. Yamada, T.; Hirata, A.; Sasabe, E.; Yoshimura, T.; Ohno, S.; Kitamura, N.; Yamamoto, T. TCDD disrupts posterior palatogenesis and causes cleft palate. J. Craniomaxillofac. Surg. 2014, 42, 1–6. [Google Scholar] [CrossRef]
  53. Lind, P.M.; Wejheden, C.; Lundberg, R.; Alvarez-Lloret, P.; Hermsen, S.A.B.; Rodriguez-Navarro, A.B.; Larsson, S.; Rannug, A. Short-term exposure to dioxin impairs bone tissue in male rats. Chemosphere 2009, 75, 680–684. [Google Scholar] [CrossRef]
  54. Dobrzyński, M.; Bazan, J.; Gamian, A.; Rosińczuk-Tonderys, J.; Parulska, O.; Całkosiński, I. The use of acetylsalicylic acid and tocopherol in protecting bone against the effects of dioxin contamination. Rocz. Ochr. Śr. 2014, 16, 300–322. [Google Scholar]
  55. Ban, Y.; Yon, J.M.; Cha, Y.; Choi, J.; An, E.S.; Guo, H.; Seo, D.W.; Kim, T.S.; Lee, S.P.; Kim, J.C.; et al. A hop extract lifenol® improves postmenopausal overweight, osteoporosis and hot flash in ovariectomized rats. evid. based complement. Alternat. Med. 2018, 2018, 2929107. [Google Scholar]
  56. Komori, T. Regulation of osteoblast differentiation by runx2. Adv. Exp. Med. Biol. 2010, 658, 43–49. [Google Scholar] [PubMed]
  57. Henderson, M.; Miranda, C.; Stevens, J.; Deinzer, M.L.; Buhler, D.R. In vitro Inhibition of Human P450 Enzymes by Prenylated Flavonoids from Hops, Humulus lupulus. Xenobiotica 2000, 30, 235–251. [Google Scholar] [CrossRef] [PubMed]
Ijerph 17 05883 g001a 550Ijerph 17 05883 g001b 550
Figure 1. (a) Average calcium concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average calcium concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Figure 1. (a) Average calcium concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average calcium concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Ijerph 17 05883 g001aIjerph 17 05883 g001b
Ijerph 17 05883 g002 550
Figure 2. (a) Average phosphorus concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average phosphorus concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Figure 2. (a) Average phosphorus concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average phosphorus concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Ijerph 17 05883 g002
Ijerph 17 05883 g003 550
Figure 3. Average magnesium concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Figure 3. Average magnesium concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Ijerph 17 05883 g003
Ijerph 17 05883 g004 550
Figure 4. (a) Average zinc concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average zinc concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Figure 4. (a) Average zinc concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average zinc concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Ijerph 17 05883 g004
Ijerph 17 05883 g005 550
Figure 5. (a) Average iron concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average iron concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Figure 5. (a) Average iron concentration (transformed variables) in the bone of the cranial vault, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold. (b) Average iron concentration (transformed variables) in the bone of the hind limb, depending on the dose of TCDD and xanthohumol, and results of the significance test. Results are represented as mean ± SD. p ≤ 0.05 was considered statistically significant. Significant p value is highlighted in bold.
Ijerph 17 05883 g005
Table
Table 1. Scheme of the animal groups formed for the experiment. The animals were divided into nine groups, including a negative control group. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Xanthohumol (XN) were administered intramuscularly to birds in different doses.
Table 1. Scheme of the animal groups formed for the experiment. The animals were divided into nine groups, including a negative control group. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Xanthohumol (XN) were administered intramuscularly to birds in different doses.
Group NumberTCDD (ug/kg b.w. i.m.)Xanthohumol (mg/kg b.w. i.m.)
I00
II010
III020
IV0.50
V0.510
VI0.520
VII20
VIII210
IX220

Share and Cite

MDPI and ACS Style

Całkosińska, A.; Dominiak, M.; Sobolewska, S.; Leśków, A.; Tarnowska, M.; Całkosiński, A.; Dobrzyński, M. The Protective Effect of Xanthohumol on the Content of Selected Elements in the Bone Tissue for Exposed Japanese Quails to TCDD. Int. J. Environ. Res. Public Health 2020, 17, 5883. https://doi.org/10.3390/ijerph17165883

AMA Style

Całkosińska A, Dominiak M, Sobolewska S, Leśków A, Tarnowska M, Całkosiński A, Dobrzyński M. The Protective Effect of Xanthohumol on the Content of Selected Elements in the Bone Tissue for Exposed Japanese Quails to TCDD. International Journal of Environmental Research and Public Health. 2020; 17(16):5883. https://doi.org/10.3390/ijerph17165883

Chicago/Turabian Style

Całkosińska, Aleksandra, Marzena Dominiak, Sylwia Sobolewska, Anna Leśków, Małgorzata Tarnowska, Aleksander Całkosiński, and Maciej Dobrzyński. 2020. "The Protective Effect of Xanthohumol on the Content of Selected Elements in the Bone Tissue for Exposed Japanese Quails to TCDD" International Journal of Environmental Research and Public Health 17, no. 16: 5883. https://doi.org/10.3390/ijerph17165883

APA Style

Całkosińska, A., Dominiak, M., Sobolewska, S., Leśków, A., Tarnowska, M., Całkosiński, A., & Dobrzyński, M. (2020). The Protective Effect of Xanthohumol on the Content of Selected Elements in the Bone Tissue for Exposed Japanese Quails to TCDD. International Journal of Environmental Research and Public Health, 17(16), 5883. https://doi.org/10.3390/ijerph17165883

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop